Hebei Lansheng Biotech Co., Ltd.
Beijing Multigrass Formulation Co., Ltd.

UPL obtains all regulatory approvals for Arysta LifeScience acquisitionqrcode

Jan. 28, 2019

Favorites Print
Jan. 28, 2019
UPL, in a press note to the exchanges, informed that the company has obtained all regulatory approvals for the acquisition of 100% stake of Arysta LifeScience.
Accordingly, the company is expected to complete the transaction with regards to acquisition by January 31, 2019, said UPL in a press release after market hours to the exchanges last Thursday.
Source: IIFL

Picture 0/1200

More from AgroNews


2020 India Pesticide Suppliers Guide 2020 Market Insight
2020 CRO & CRAO Manual 2020 Biologicals Special
2020 Latin America Focus 2020 Formulation & Adjuvant Technology
I wanna post a press Comment


Subscribe Email: *
Mobile Number:  


Picture 0/1200

Subscribe to daily email alerts of AgroNews.